Senior Lecturer in Pharmacy Practice, University of South Australia
Dr. Jacinta Johnson is a credentialled Advanced Practice pharmacist with over 10 years of experience in hospital pharmacy. She currently practices across two settings as Senior Lecturer in Pharmacy Practice at the University of South Australia, and as Senior Pharmacist, supporting development of research capacity and culture within the SA Pharmacy, the statewide public hospital pharmacy service. In addition, Jacinta is also a National Board Director of the Society of Hospital Pharmacists of Australia (SHPA), and Chairs the SHPA Residency Advisory Group, the body responsible for guiding development and implementation Foundation and Advanced Training Residencies throughout Australia.
Dr Johnson holds a PhD in Pharmacology from the University Adelaide and has a strong track record of conducting applied research to meet needs identified by the health sector. Her research broadly explores topics related to medicines safety and the role of the pharmacist in this field. Additionally, she has a passion for practitioner development and collaborative health care. Her clinical expertise relates to drugs and the brain, with a focus on the fields of pain management, headache and migraine, Parkinson’s disease and addiction medicine.
Dr Johnsons influence and expertise have been recognised through several awards within the pharmacy profession. In 2018, she was named the Australian Early Career Pharmacist of the Year by the peak body for pharmacists, the Pharmaceutical Society of Australia (PSA), and in 2019 she was named the National Emerging Leader of the Year by the Society of Hospital Pharmacists Australia (SHPA). These followed two state awards, the SA/NT PSA Early Career Pharmacist of the Year and the SHPA ‘PL Jeffs’ Early Career Pharmacist award. In 2022, Dr Johnson and her team received the SHPA SA/NT Team Innovation Award for their work supporting hospital pharmacy research capability, and the SA Pharmacy Award for Excellence in Research and Building Collaborative Partnerships.
What is minoxidil, the anti-balding hair growth treatment? Here’s what the science says
Mar 16, 2024 07:15 am UTC| Insights & Views Science
Hair loss (also known as alopecia) often affects the scalp but can occur anywhere on the body. Its very common and usually nothing to worry about; about half of Australian men show signs of visible baldness at age 50 and...
Trade War Escalates: China Strikes Back